Nextage Therapeutics Ltd (NXTG) - Cash Flow Conversion Efficiency

Latest as of June 2022: -0.730x

Based on the latest financial reports, Nextage Therapeutics Ltd (NXTG) has a cash flow conversion efficiency ratio of -0.730x as of June 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-1.72 Million ≈ $-4.61K USD) by net assets (ILA2.36 Million ≈ $6.32K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Nextage Therapeutics Ltd (NXTG) total market value for the company's overall valuation and market capitalisation.

Nextage Therapeutics Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Nextage Therapeutics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Nextage Therapeutics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nextage Therapeutics Ltd ranked by their cash flow conversion efficiency. See Nextage Therapeutics Ltd (NXTG) cash flow to debt to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Witbe Net SA PA:ALWIT	0.366x
Stenocare AS CO:STENO	0.180x
Arbor Metals Corp V:ABR	-0.006x
FIREFOX GOLD CORP. F:FIY	N/A
Biofil Chemicals & Pharmaceuticals Limited NSE:BIOFILCHEM	-0.167x
Singularity Future Technology Ltd NASDAQ:SGLY	-0.798x
Qlife Holding AB ST:QLIFE	-2.207x
Spacetalk Ltd AU:SPA	-0.153x

Annual Cash Flow Conversion Efficiency for Nextage Therapeutics Ltd (2017–2024)

The table below shows the annual cash flow conversion efficiency of Nextage Therapeutics Ltd from 2017 to 2024. View NXTG share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	ILA-5.54 Million ≈ $-14.84K	ILA-795.00K ≈ $-2.13K	0.144x	-82.62%
2023-12-31	ILA-2.74 Million ≈ $-7.34K	ILA-2.26 Million ≈ $-6.06K	0.826x	-94.14%
2022-12-31	ILA-426.00K ≈ $-1.14K	ILA-6.01 Million ≈ $-16.12K	14.113x	+283.24%
2021-12-31	ILA516.00K ≈ $1.38K	ILA-3.97 Million ≈ $-10.65K	-7.702x	-76.95%
2020-12-31	ILA1.45 Million ≈ $3.89K	ILA-6.31 Million ≈ $-16.92K	-4.352x	-442.90%
2019-12-31	ILA3.66 Million ≈ $9.80K	ILA-2.93 Million ≈ $-7.86K	-0.802x	-126.70%
2018-12-31	ILA-1.65 Million ≈ $-4.42K	ILA-4.95 Million ≈ $-13.28K	3.003x	+334.96%
2017-12-31	ILA4.44 Million ≈ $11.90K	ILA-5.67 Million ≈ $-15.20K	-1.278x	--

About Nextage Therapeutics Ltd

TA:NXTG Israel Drug Manufacturers - Specialty & Generic

Market Cap

$5.79 Million

ILA2.16 Billion ILA

Market Cap Rank

#28410 Global

#410 in Israel

Share Price

ILA64.10

Change (1 day)

-17.72%

52-Week Range

ILA64.10 - ILA85.00

All Time High

ILA5080.00